Showing results (31-40 of 707) with videos related to

Sort By:
Pageof 71
Clinical Lymphoma, Myeloma & Leukemia|April 16, 2020
Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab OzogamicinTalha Badar, Aniko Szabo, Martha Wadleigh, et al.
International Journal of Hematology|August 26, 2016
Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopeniaJulie Waisbren, Shira Dinner, Jessica Altman, et al.
Blood Advances|May 27, 2020
Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomabTalha Badar, Aniko Szabo, Anjali Advani, et al.
Leukemia & Lymphoma|April 11, 2024
The mechanism of action, pharmacological characteristics, and clinical utility of the amyloid depleter birtamimab for the potential treatment of AL amyloidosisGiovanni Palladini, Michaela Liedtke, Wagner Zago, et al.
Cancer Immunology Research|February 26, 2015
Mass cytometry analysis shows that a novel memory phenotype B cell is expanded in multiple myelomaLeo Hansmann, Lisa Blum, Chia-Hsin Ju, et al.
Blood|April 17, 2010
Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6Michaela Liedtke, Paul M Ayton, Tim C P Somervaille, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 5, 2011
Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategiesBrandon C Varr, Michaela Liedtke, Sally Arai, et al.
Cancer|December 1, 2020
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemiaTalha Badar, Aniko Szabo, Shira Dinner, et al.
Blood|June 16, 2017
Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosisGregory P Kaufman, Stanley L Schrier, Richard A Lafayette, et al.
Cancers|August 14, 2025
Ibrutinib in Combination with Lenalidomide Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma (AFT-15)Yvonne Efebera, Vera Suman, Shira Dinner, et al.
Pageof 71